Debevoise Advises Evercore and J.P. Morgan as Financial Advisors to Akebia Therapeutics in its $1.3 Billion Merger with Keryx Biopharmaceuticals

28 June 2018

Debevoise & Plimpton LLP is advising Evercore Group L.L.C. and J.P. Morgan Securities L.L.C. as financial advisors to Akebia Therapeutics in its $1.3 billion merger with Keryx Biopharmaceuticals.

The Debevoise team is led by partners Andrew L. Bab and Jeffrey J. Rosen and includes associate Claire Hansen Suni.

Debevoise & Plimpton LLP is a premier law firm with market-leading practices, a global perspective and strong New York roots. We deliver effective solutions to our clients’ most important legal challenges, applying clear commercial judgment and a distinctively collaborative approach.